Qingdao Medical Journal 2012 Issue 1 xin sheng yin qiu jun jia mo pei yang fang fa yu bao cun

xin sheng yin qiu jun jia mo pei yang fang fa yu bao cun
wang zuo ; yang shu guo ; feng gui xiang

..............page:65

zen yang zuo hao yu fang jie zhong er tong de xin li hu li
zhang xiao fang

..............page:58-59

qian tan ru he ti gao chu fang zhi liang
jiang hai hua

..............page:54-55

chuan ci mo ni ren zai yi xue sheng lin chuang ji neng pei xun ji kao he zhong de ying yong yan jiu
qi cai xia ; wang bao zhong

..............page:67-68

Correlation among expression of CD105 and E-cadherin in breast cancer
SUN Xu-ling;HUANG Gui-lin

..............page:5-7

Clinical efficacy of Rigan and Arginine in the treatment of hepatic encephalopathy caused by cirrhosis of liver
ZHANG Ling;XU Peng-tao;ZHANG Yu

..............page:8-10

xia zuo ji xing zhi chi guan zhou yan yu di san mo ya zu sheng wei zhi de fen xi
zhu huai hong ; chen chun ying

..............page:33-34

shou shu shi shi xi hu shi de xin li ji dai jiao gou tong ce lue
wang hai rui

..............page:69

Pharmaceutical screening of active fraction of haemostasis in Agi
XUE Yan;WANG Tong-zhi

..............page:40-42

tong guo dui hu chu qi no nong du de ce ding tan tao shu li die ji shun er ning lian he yu dan yao dui xiao chuan zhi liao xiao guo de bi jiao
dai si hong ; chai jing ; jiang ping

..............page:18-20

Study on the influence of low-dose mifepristone in reproductive endocrine system
WANG Xiu-li;LUAN Qiang;LIU Ping

..............page:11-13

Assays and clinical significance of serum myocardial enzymes in the children with hand, foot and mouth disease
HAN Peng;CHU Rui-hai;ZHANG Cai-cai;GUO Xin

..............page:14-16

stanford b xing zhu dong mai jia ceng 25 li ji jiu hu li ti hui
gao hai ying

..............page:61-62

men zhen tui huan hao de yuan yin fen xi ji dui ce
dong shu yin ; zhao yan ling

..............page:63-64

zhi bi tai dui 2 xing tang niao bing huan zhe xue zhi dai xie wen luan de ying xiang
li qing chuan

..............page:26-27

xin li gan yu dui po gong chan shou shu bing ren qing xu de ying xiang
zuo li ; li yuan ; wang hui ling

..............page:56-57

zi gong zuo mo xia ji liu tuo chui zhi zi gong da chu xue 1 li
han shu qin ; ji shu xia ; wu jian

..............page:27

jian kang jiao yu dui men zhen tang niao bing huan zhe de zuo yong
ren shu qin

..............page:79-80

wei zhong bing ren chang nei ying yang zhi chi fen xi
qiu wen zhen

..............page:29-30

zhong zheng nao chu xue huan zhe zao qi qi guan qie kai de lin chuang yi yi
zhang xiao xi ; tian yan rong ; guo zuo ; qiu zuo zuo

..............page:34-35

ru xian ai gai liang gen zhi shu ba chu yin liu guan hou pi xia ji ye de lin chuang yan jiu
zhang yong

..............page:36-37

qian xi xiao du gong ying zhong xin shi bao de chang jian yuan yin ji fang fan
lu wei

..............page:66

Analysis of adverse reactions in 62 cases of patients with pegylated interferon
FENG Yan;LONG Hui;CHEN Shu-xin

..............page:16-17

bu tong shou shu fang shi dui zao qi ru xian ai huan zhe shu hou sheng huo zhi liang de ying xiang
hou ji xue ; wang jing

..............page:21-22

Discussion for the legal system of adverse reactions mandary reporting
TAN Xiong-si;TANG Tie-xin

..............page:73-77

shi xing hu li shi xi dai jiao xiao zu ji yun yong shi xi dai jiao jin cheng biao zai lin chuang hu li jiao xue guan li gong zuo zhong de tan suo
wang zi feng ; zhang ying ; li ping

..............page:70-72

qian tan yi liao ji gou ru he shi shi hui ji nei kong zhi du
zhang zuo ; li zhi rong

..............page:77-78

Establishment of a stable siRNA-NUAK1 95D cell line
HOU Cheng-hao;TAO Rong;SHI Li-hong;SU Chao;ZHENG Shi-liang;ZHANG Bao-gang

..............page:1-4

schirmer tear de ying yong yu gan yan zheng bing yin fen xi
peng shu bi

..............page:23-25

yao shi ru he shen ru kai zhan lin chuang yao xue gong zuo
ding gen lian ; di cai hua

..............page:52-53

44 li qing nian ru xian ai lin chuang bing li te dian fen xi
li zhi gang ; huang gui lin

..............page:31-32

qian tan an shi liao fa zai wei chi xing xue ye tou xi huan zhe zhong de ying yong
liu cui rong ; yang rui rong

..............page:60-61

6li shang zuo zuo ai de ying xiang zheng xiang fen xi
wang you kang

..............page:38-39

hu nan sheng bu fen xiang zhen wei sheng yuan yi xue jian yan diao cha xian zhuang fen xi yu si kao
liu chuan jia ; gao zuo ran ; zhang zheng qiang ; zhang zuo

..............page:45-47

106 li gao ling ji xing chang geng zu huan zhe zhen zhi fen xi
lv hai tao ; zhang jian sheng ; wu hui guo

..............page:28-29

bu dian xing xin jiao tong bing ren de hu li ti hui
jia lin lin ; sun min ; wu yan ; chen li juan

..............page:64

san yin xing ru xian ai yan jiu jin zhan
wang yan lin ; huang gui lin

..............page:48-51

2012 nian qing dao shi wei sheng ji shu ren yuan ji xu yi xue jiao yu shi ti ( yi )

..............page:80

xin xi dong tai

..............page:72,封3

Tanreqing and Pudilan combination therapy for HFMD clinical observation
ZHANG Cai-cai;CHU Rui-hai;HAN Peng;GUO Xin

..............page:42-44